Shenzhen Lifotronic Technology Co
Shenzhen Lifotronic Technology Co., Ltd. research, develops, manufactures, and markets medical devices for diagnostics, therapy, clinical medicine, skin, and human health related purposes in China. The company offers IVD products, such as HPLC, ECLIA, and hematology system; rapid test, molecular and POCT diagnostics. It also offers therapeutic products comprising respiratory and ICU, and wound ca… Read more
Market Cap & Net Worth: Shenzhen Lifotronic Technology Co (688389)
Shenzhen Lifotronic Technology Co (SHG:688389) has a market capitalization of $777.29 Million (CN¥5.70 Billion) as of March 18, 2026. Listed on the SHG stock exchange, this China-based company holds position #11779 globally and #2833 in its home market, demonstrating a 1.53% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Shenzhen Lifotronic Technology Co's stock price CN¥13.31 by its total outstanding shares 428485730 (428.49 Million).
Shenzhen Lifotronic Technology Co Market Cap History: 2019 to 2026
Shenzhen Lifotronic Technology Co's market capitalization history from 2019 to 2026. Data shows change from $927.65 Million to $777.29 Million (-5.44% CAGR).
Shenzhen Lifotronic Technology Co Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Shenzhen Lifotronic Technology Co's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.76x
Shenzhen Lifotronic Technology Co's market cap is 0.76 times its annual revenue
0.67x
Higher than industry averageLatest Price to Earnings (P/E) Ratio
2.52x
Shenzhen Lifotronic Technology Co's market cap is 2.52 times its annual earnings
1.95x
Higher than industry averageWhat These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2019 | $927.65 Million | $422.64 Million | $100.56 Million | 2.19x | 9.22x |
| 2020 | $1.19 Billion | $553.82 Million | $143.95 Million | 2.15x | 8.28x |
| 2021 | $1.31 Billion | $778.11 Million | $190.35 Million | 1.69x | 6.91x |
| 2022 | $1.03 Billion | $983.04 Million | $251.48 Million | 1.05x | 4.10x |
| 2023 | $1.31 Billion | $1.15 Billion | $328.58 Million | 1.15x | 4.00x |
| 2024 | $869.56 Million | $1.15 Billion | $345.39 Million | 0.76x | 2.52x |
Competitor Companies of 688389 by Market Capitalization
Companies near Shenzhen Lifotronic Technology Co in the global market cap rankings as of March 18, 2026.
Key companies related to Shenzhen Lifotronic Technology Co by market ranking:
- Abbott Laboratories (NYSE:ABT): Ranked #78 globally with a market cap of $191.37 Billion USD.
- Stryker Corporation (NYSE:SYK): Ranked #154 globally with a market cap of $121.03 Billion USD.
- Medtronic PLC (NYSE:MDT): Ranked #168 globally with a market cap of $113.17 Billion USD.
- Boston Scientific Corp (NYSE:BSX): Ranked #185 globally with a market cap of $105.26 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #78 | Abbott Laboratories | NYSE:ABT | $191.37 Billion | $110.71 |
| #154 | Stryker Corporation | NYSE:SYK | $121.03 Billion | $349.11 |
| #168 | Medtronic PLC | NYSE:MDT | $113.17 Billion | $88.44 |
| #185 | Boston Scientific Corp | NYSE:BSX | $105.26 Billion | $71.20 |
Shenzhen Lifotronic Technology Co Historical Marketcap From 2019 to 2026
Between 2019 and today, Shenzhen Lifotronic Technology Co's market cap moved from $927.65 Million to $ 777.29 Million, with a yearly change of -5.44%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | CN¥777.29 Million | +2.54% |
| 2025 | CN¥758.02 Million | -12.83% |
| 2024 | CN¥869.56 Million | -33.85% |
| 2023 | CN¥1.31 Billion | +27.49% |
| 2022 | CN¥1.03 Billion | -21.57% |
| 2021 | CN¥1.31 Billion | +10.33% |
| 2020 | CN¥1.19 Billion | +28.46% |
| 2019 | CN¥927.65 Million | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of Shenzhen Lifotronic Technology Co was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $777.29 Million USD |
| MoneyControl | $777.29 Million USD |
| MarketWatch | $777.29 Million USD |
| marketcap.company | $777.29 Million USD |
| Reuters | $777.29 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.